Cargando…
Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software
INTRODUCTION: Studies have shown that proton pump inhibitors (PPIs) increase the brain burden of amyloid-beta (Aβ) and also create vitamin B(12) deficiency. However, these two phenomena have deleterious effect on cognition and Alzheimer’s disease (AD). Since the use of PPIs has increased tremendousl...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696341/ https://www.ncbi.nlm.nih.gov/pubmed/26714488 http://dx.doi.org/10.1186/s13195-015-0164-8 |
_version_ | 1782407781247090688 |
---|---|
author | Akter, Sanjida Hassan, Md. Rajib Shahriar, Mohammad Akter, Nahia Abbas, Md. Golam Bhuiyan, Mohiuddin Ahmed |
author_facet | Akter, Sanjida Hassan, Md. Rajib Shahriar, Mohammad Akter, Nahia Abbas, Md. Golam Bhuiyan, Mohiuddin Ahmed |
author_sort | Akter, Sanjida |
collection | PubMed |
description | INTRODUCTION: Studies have shown that proton pump inhibitors (PPIs) increase the brain burden of amyloid-beta (Aβ) and also create vitamin B(12) deficiency. However, these two phenomena have deleterious effect on cognition and Alzheimer’s disease (AD). Since the use of PPIs has increased tremendously for the last few years, it is of great public health importance to investigate the cognitive impact of PPIs. Hence, the purpose of this study was to investigate the degree of neuropsychological association of each PPI with different cognitive functions. METHODS: Sixty volunteers of either gender were recruited and divided randomly into six groups: five test groups for five classes of PPIs and one control group. All the groups participated in the five computerized neuropsychological tests (nine subtests) of the Cambridge Neuropsychological Test Automated Battery twice: at the beginning of the study and 7 days thereafter. RESULTS: We found statistically and clinically significant impairment in visual memory, attention, executive function, and working and planning function. One-way analysis of variance findings showed that all PPIs had a similar negative impact on cognition. However, paired-samples t tests indicated that omeprazole showed significant (p < 0.05) results in seven subtests; lansoprazole and pantoprazole showed significant results in five subtests; and rabeprazole showed significant results in four subtests. Among five classes of PPIs, esomeprazole showed comparatively less impact on cognitive function with significant results in three subtests. CONCLUSIONS: The present study reveals for the first time that different PPIs have varying degrees of influence on different cognitive domains and have associations with AD. These findings should be considered when balancing the risks and benefits of prescribing these medications. A study done for a longer period of time with a larger sample size might yield better results. |
format | Online Article Text |
id | pubmed-4696341 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46963412015-12-31 Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software Akter, Sanjida Hassan, Md. Rajib Shahriar, Mohammad Akter, Nahia Abbas, Md. Golam Bhuiyan, Mohiuddin Ahmed Alzheimers Res Ther Research INTRODUCTION: Studies have shown that proton pump inhibitors (PPIs) increase the brain burden of amyloid-beta (Aβ) and also create vitamin B(12) deficiency. However, these two phenomena have deleterious effect on cognition and Alzheimer’s disease (AD). Since the use of PPIs has increased tremendously for the last few years, it is of great public health importance to investigate the cognitive impact of PPIs. Hence, the purpose of this study was to investigate the degree of neuropsychological association of each PPI with different cognitive functions. METHODS: Sixty volunteers of either gender were recruited and divided randomly into six groups: five test groups for five classes of PPIs and one control group. All the groups participated in the five computerized neuropsychological tests (nine subtests) of the Cambridge Neuropsychological Test Automated Battery twice: at the beginning of the study and 7 days thereafter. RESULTS: We found statistically and clinically significant impairment in visual memory, attention, executive function, and working and planning function. One-way analysis of variance findings showed that all PPIs had a similar negative impact on cognition. However, paired-samples t tests indicated that omeprazole showed significant (p < 0.05) results in seven subtests; lansoprazole and pantoprazole showed significant results in five subtests; and rabeprazole showed significant results in four subtests. Among five classes of PPIs, esomeprazole showed comparatively less impact on cognitive function with significant results in three subtests. CONCLUSIONS: The present study reveals for the first time that different PPIs have varying degrees of influence on different cognitive domains and have associations with AD. These findings should be considered when balancing the risks and benefits of prescribing these medications. A study done for a longer period of time with a larger sample size might yield better results. BioMed Central 2015-12-27 /pmc/articles/PMC4696341/ /pubmed/26714488 http://dx.doi.org/10.1186/s13195-015-0164-8 Text en © Akter et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Akter, Sanjida Hassan, Md. Rajib Shahriar, Mohammad Akter, Nahia Abbas, Md. Golam Bhuiyan, Mohiuddin Ahmed Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software |
title | Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software |
title_full | Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software |
title_fullStr | Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software |
title_full_unstemmed | Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software |
title_short | Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software |
title_sort | cognitive impact after short-term exposure to different proton pump inhibitors: assessment using cantab software |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696341/ https://www.ncbi.nlm.nih.gov/pubmed/26714488 http://dx.doi.org/10.1186/s13195-015-0164-8 |
work_keys_str_mv | AT aktersanjida cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware AT hassanmdrajib cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware AT shahriarmohammad cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware AT akternahia cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware AT abbasmdgolam cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware AT bhuiyanmohiuddinahmed cognitiveimpactaftershorttermexposuretodifferentprotonpumpinhibitorsassessmentusingcantabsoftware |